Noul is committed to addressing critical healthcare challenges with innovative diagnostic solutions. Our flagship platform, miLab™, enhances the diagnostic workflow for diseases like malaria, blood cell abnormalities, and cervical cancer. By integrating advanced AI technology, miLab™ ensures rapid, accurate, and accessible diagnostics, even in resource-limited settings. Noul's mission is to impact over a billion lives globally by improving medical access and advancing cancer treatment. We are at the forefront of on-device AI healthcare, driving significant improvements in diagnostic efficiency and accuracy.
